
洪秀熙
Partner概要
Su Hee Hong is a partner at Shin & Kim whose main practice areas include bio- and healthcare, M&A, foreign investment, and corporate governance.
Ms. Hong advises clients on M&A, joint ventures, corporate restructuring, foreign investment, local subsidiaries establishment, and investment attraction, as well as a wide range of issues arising in the course of business operations. With extensive experience in the healthcare sector, including pharmaceuticals, biotechnology, medical devices, food, cosmetics, and medical care, Ms. Hong provides comprehensive advice to healthcare companies.
Ms. Hong completed LL.M. program at Columbia Law School in 2015 and worked as a seconded lawyer at Australian law firm Gilber + Tobin from September 2015 to February 2016.
関連業務内容
経歴
- 2024-PresentMember of the Cosmetic Advertising Review Committee, the Korea Cosmetic Association
- 2020Member of the 11th Medical Device Advertising Advance Review Committee, the Korea Medical Devices Industry Association
- 2016.2-2016.5Secondment in Mercedes-Benz
- 2008-PresentShin & Kim LLC
- 2015-2016Gilbert + Tobin Sydney Office, Australia (Visiting Lawyer)
- 2015Passed New York State Bar Exam
- 2006-2008Judicial Research & Training Institute of the Supreme Court of Korea
主な実績
Bio-Healthcare
- Advised multinational pharmaceutical and medical device companies on feasibility, licensing, insurance and market access, etc. of new businesses
- Advised and defended against KFDA penalties related to pharmaceuticals, quasi-drugs, medical devices, food, nutraceuticals, livestock products, and cosmetics
- Advised on labeling and advertising of pharmaceuticals, medical devices, food, nutraceuticals, cosmetics, etc.
- Advised on response to consumer complaints related to pharmaceuticals, medical devices, food, cosmetics, etc.
- Advised a pharmaceutical and medical device business association on system improvement recommendation to the KFDA, etc.
- Advised on rebates and other compliance matters
- Drafting and review of contracts such as joint research agreements, license agreements, sales agreements, clinical trial consignment agreements, manufacturing consignment agreements, exclusive sales agreements, overseas investment agreements, etc. for pharmaceutical companies, medical device companies, biotech companies, CROs, etc. and defended in related disputes
- Advised large hospitals and genetic testing agencies on medical law and bioethics law, etc.
- Advised platform companies, insurance companies, etc. on new businesses in the healthcare sector and use of healthcare data
- Advised on legislation for the establishment of a for-profit hospital in Incheon Free Economic Zone and reviewed its business structure
M&A
- Valeo's joint venture and restructuring projects in Korea
- Lotte Healthcare's investment in Theragen Health Co., Ltd.
- Schaeffler's sale of the chain drive business unit
- Bukwang Pharm's majority shareholder's sale of interest in OCI
- IMM PE's acquisition of Kolmar Korea and Kolmar Pharma Co., Ltd.
- Merger of Praxair Korea Co., Ltd. and Linde SG Korea Co., Ltd.
- Linde Group's spin-off of Linde Korea (under a divestiture order by the Korea Fair Trade Commission)
- Technicolor's acquisition of the set-top box business division of LG Electronics Inc.
- AIG's sale of IFC (the largest real estate sale ever in Korea)
- Linde Korea's acquisition of Air Liquide Korea's on-site and bulk businesses
- EcoPro GEM's investment attraction from BRV
- Quintessa PE's investment in Kolmar Korea Holdings, Kolmar Pharma Co., Ltd, Kolmar BNH Co, etc.
- Mirae Asset Securities PE's investment in Jetema Co., Ltd.
- Korea Environment Corporation's acquisition of Samhyub Green Tech Co., Ltd. and Eco Green Co., Ltd.
- Bukwang Pharm's investment in biotech venture capital firms
学歴
- 2015Columbia Law School (LL.M.)
- 2011Seoul National University Graduate School of Law, Completion of Master program (Corporate Law)
- 2006Seoul National University School of Law (LL.B.)
資格
- 2008Admitted to bar, Korea
言語
Korean, English
メディア
-
2022.11.29
-
ニュースレター 医療機器法の改正による医療機器広告の自律審議制度の導入
2021.07.06 -
2020.12.09
-
2020.11.27